menu
    • menu

    Company profile for Aska Pharmaceutical

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Manufacturing, sale and import/export of pharmaceuticals, veterinary medicines, quasi-drugs, foods, and medical devices. ASKA Pharmaceutical Holdings Co., Ltd. (Headquarter: Minato-ku, Tokyo/ President, Representative Director: Takashi Yamaguchi), announced the following organizational restructuring and personnel appointments, effective April 1st, 2022, respectively

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aska Pharmaceuticaljapan Flag
    Country
    Country
    Japan
    Address
    Address
    5-1, Shibaura 2-Chome, Minato-ku, Tokyo 108-8532
    Telephone
    Telephone
    +81-3-5484-8361
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aska-pharma.co.jp/english/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASKA, KinoPharma unite to treat cervical dysplasia
    ASKA, KinoPharma unite to treat cervical dysplasia

    15 Jan 2020

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/15245/aska-kinopharma-unite-to-treat-cervical-dysplasia.html

    BIOSPECTRUM ASIA
    15 Jan 2020
    Share Share
    ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement
    ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement

    14 Jan 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aska-pharmaceutical-co-ltd-and-kinopharma-inc-enter-into-option-agreement-for-treatment-of-cervical-dysplasia-300986230.html

    PR NEWSWIRE
    14 Jan 2020
    Share Share
    UAE’s Neopharma and ASKA of Japan to build drug plant in India in $53M JV
    UAE’s Neopharma and ASKA of Japan to build drug plant in India in $53M JV

    04 May 2018

    // Joseph Keenan FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/uae-s-neopharma-and-aska-japan-53m-jv-to-build-drug-plant-india

    Joseph Keenan FIERCE PHARMA
    04 May 2018
    Share Share
    Aska, Neopharma arm team up for Rs350 Cr venture
    Aska, Neopharma arm team up for Rs350 Cr venture

    27 Apr 2018

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/28/10779/aska-neopharma-arm-team-up-for-rs350-cr-venture.html

    BIOSPECTRUM
    27 Apr 2018
    Share Share
    Aska buys option to commercialize Pieris' potential EPO rival in Japan
    Aska buys option to commercialize Pieris' potential EPO rival in Japan

    28 Feb 2017

    // Gareth MacDonald BIOPHARMA

    http://www.biopharma-reporter.com/Markets-Regulations/Aska-buys-option-to-commercialize-Pieris-potential-EPO-rival-in-Japan

    Gareth MacDonald BIOPHARMA
    28 Feb 2017
    Share Share
    Chugai to Transfer Mercazole & Propacil Marketing Rights to Aska Pharma
    Chugai to Transfer Mercazole & Propacil Marketing Rights to Aska Pharma

    03 Apr 2015

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=87578&sid=2

    PHARMABIZ
    03 Apr 2015
    Share Share

    ABOUT THIS PAGE

    Contact Aska Pharmaceutical and get a quotation

    Aska Pharmaceutical is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Soblidotin bulk offered by Aska Pharmaceutical

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search